Ireland· IE-PA-EU/1/19/1419/003
Trepulmix 5 mg/ml solution for infusion
A treprostinil product containing treprostinil sodium, registered in Ireland by Scipharm S.à.r.l.. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Treprostinil is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AC21 (treprostinil), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Treprostinil · ATC B01AC21
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Treprostinil sodium
- Manufacturer
- Scipharm S.à.r.l.
- Country
- Ireland (IE)
- ATC code
- B01AC21
- ATC class
- Treprostinil
- Defined daily dose
- 4.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/19/1419/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
371 interactions on record for treprostinil.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Treprostinil · interactions on record
371 records
- 34 severe
- 295 moderate
- 2 minor
- 40 info
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Treprostinil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsTrepulmix 5 mg/ml, oplossing voor infusieScipharm Sarl
- United StatesOrenitramUnited Therapeutics Corporation
- FinlandRemodulinFerrer International, SA
- PolandRemodulinFerrer International S.A.
- CzechiaREMODULINFerrer Internacional, S.A., Barcelona
- SpainTREPROSTINILO DR REDDYS 1 MG/ML SOLUCION PARA PERFUSION EFGReddy Pharma Iberia S.A.
- BelgiumRemodulin 1 mg/mlFerrer Internacional
- FranceREMODULIN 1 mg/ml, solution pour perfusionFERRER INTERNACIONAL (ESPAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Remodulin, Treposa
- Belgium · Remodulin, Tresuvi
- Bulgaria · Тресуви
- Cyprus · Remodulin
- Czechia · Remodulin, Treprostinil Tillomed
- Germany · Remodulin, Treprostinil Beta
- Denmark · Remodulin, Treprostinil Tillomed
- Estonia · Remodulin, Tresuvi
- Spain · Treprostinilo Dr. Reddys, Treprostinilo Ferrer
- Finland · Remodulin, Treposa
- France · Remodulin, Treposuvi
- United Kingdom (Northern Ireland) · Treprostinil Dr. Reddy's Laboratories (Uk), Treprostinil Tillomed
- Greece · Remodulin, Treprostinil Tillomed
- Croatia · Remodulin, Treprostinil Tillomed
- Hungary · Remodulin, Treprostinil Zentiva
- Iceland · Remodulin, Trepulmix
- Italy · Remodulin, Treprostinil Dr. Reddy’s
- Liechtenstein · Trepulmix
- Lithuania · Remodulin, Treprostinil Tillomed
- Luxembourg · Remodulin
- Latvia · Remodulin, Treposuvi
- Malta · Tresuvi
- Netherlands · Remodulin, Treposuvi
- Norway · Remodulin, Treprostinil Tillomed
- Poland · Remodulin, Treprostinil Reddy
- Portugal · Remodulin, Treprostinilo Tillomed
- Romania · Tresuvi
- Sweden · Remodulin, Treprostinil Tillomed
- Slovenia · Remodulin, Treprostinil Amomed
- Slovakia · Remodulin, Treprostinil Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8b640ea-dbc0-4604-9a1b-5bc03e54312d GET /v1/drugs/e8b640ea-dbc0-4604-9a1b-5bc03e54312d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"B01AC21"
],
"strength": null,
"pa_number": "EU/1/19/1419/003",
"substances": [
"Treprostinil sodium"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "03/04/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about treprostinil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.